Alternatively, the extension of CFTR molecular testing to include more expansive panels or full gene sequencing cannot address the initial sensitivity issues with IRT and has the unfavorable effect of enriching for CFSPID cases [22,26]. Here, CFTR is linked to CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.